about
GPR109A (PUMA-G/HM74A) mediates nicotinic acid-induced flushingNiacin, an old drug with a new twistATP-binding cassette transporters G1 and G4 mediate cellular cholesterol efflux to high-density lipoproteinsGenetic and environmental variation in serum lipoproteins in relation to coronary heart disease.Cholesterol kinetics in subjects with bile fistula. Positive relationship between size of the bile acid precursor pool and bile acid synthetic rate.Dietary fat increases high density lipoprotein (HDL) levels both by increasing the transport rates and decreasing the fractional catabolic rates of HDL cholesterol ester and apolipoprotein (Apo) A-I. Presentation of a new animal model and mechanistiInternalization of the human nicotinic acid receptor GPR109A is regulated by G(i), GRK2, and arrestin3.Future of GPR109A agonists in the treatment of dyslipidaemia.Increased apo A-I and apo A-II fractional catabolic rate in patients with low high density lipoprotein-cholesterol levels with or without hypertriglyceridemia.A low-fat diet decreases high density lipoprotein (HDL) cholesterol levels by decreasing HDL apolipoprotein transport ratesNiacin: another look at an underutilized lipid-lowering medication.Plasma high density lipoproteins. Metabolism and relationship to atherogenesis.Mechanism of action of gemfibrozil on lipoprotein metabolism.Transfers and exchanges of esterified cholesterol between plasma lipoproteins.Alcohol and high-density lipoproteins.Nicotinic Acid Accelerates HDL Cholesteryl Ester Turnover in Obese Insulin-Resistant Dogs.Novel HDL-directed pharmacotherapeutic strategies.Pharmacogenomic application of the haptoglobin genotype in the treatment of HDL dysfunctionNicotinic acid: an old drug with a promising futureKidney Function as a Determinant of HDL and Triglyceride Concentrations in the Australian Population.Multicompartmental analysis of cholesterol metabolism in man. Quantitative kinetic evaluation of precursor sources and turnover of high density lipoprotein cholesterol esters.Transport of apolipoproteins A-I and A-II by human thoracic duct lymphRadioimmunoassay studies of human apolipoprotein E.Effects of nicotinic acid therapy on plasma high density lipoprotein subfraction distribution and composition and on apolipoprotein A metabolism.Quantitation of the transfer of surface phospholipid of chylomicrons to the high density lipoprotein fraction during the catabolism of chylomicrons in the rat.Human intestinal lipoproteins. Studies in chyluric subjects.Metabolic fate of chylomicron phospholipids and apoproteins in the rat.Impact of a traditional dietary supplement with coconut milk and soya milk on the lipid profile in normal free living subjects.Extended-release niacin alters the metabolism of plasma apolipoprotein (Apo) A-I and ApoB-containing lipoproteins.The mechanism and mitigation of niacin-induced flushing.Apolipoprotein E synthesis in human kidney, adrenal gland, and liver.Emerging options in the treatment of dyslipidemias: a bright future?High-density lipoprotein cholesterol: methods and clinical significance.HDL heterogeneity and atherosclerosis.Plasma lipid concentrations in college students performing self-selected exercise.Lipoprotein cholesteryl ester production, transfer, and output in vivo in humans.Apolipoprotein A-I, A-II, and VLDL-B-100 metabolism in men: comparison of a low-fat diet and a high-monounsaturated fatty acid diet.High-Density Lipoprotein Function in Cardiovascular Disease and Diabetes Mellitus.Rethinking reverse cholesterol transport and dysfunctional high-density lipoproteinsSynthesis and Development of Lipoprotein-Based Nanocarriers for Light-Activated Theranostics
P2860
Q24536109-6B86B2A1-A1B7-4634-B9F9-B24F272EFD9DQ27002774-E9911138-234D-47FE-94F5-5AF82CC9ADC9Q28594013-714716E6-561E-4229-BA7F-48DEE01B727BQ33584798-29023B3F-A4E7-4EC6-B301-B5ED3D459995Q33893003-14CB8A5C-C840-450A-BD8A-DFDE11BF85DFQ33896520-2C1E0057-1D6C-4596-9A13-ADF41139CC21Q33991193-391190B4-7C83-407B-97E2-FD009919621DQ34171831-920A6CFB-13AB-4A0A-8572-F171FDB79499Q34236815-840FA552-243D-4CF8-ABA0-734E99A96F20Q34240202-942B7B35-22D6-497C-894C-AED12F49FFE1Q34255686-791DEE82-3E69-4A54-A8DF-796266FDDF00Q34257420-FBC18C11-706C-4A97-BC2A-AA0E319BC869Q34628487-0956CD54-5862-4C1F-ADB2-0436B90A86C0Q34662113-2E9848D6-A4D1-4186-B5F8-DB256067E55CQ35229134-54429B39-7E0B-4D03-A25D-2668DA1B9391Q35772231-5F0F5177-74E4-4306-9938-F73C2CB336CEQ35860020-BF1F406E-13FA-4DB4-9992-EA9B7696AC0FQ36441429-FF23E508-168B-4E7D-8958-CBD245543A58Q36497035-A7BAA352-DA2E-45A1-9974-1CE0A791C0BFQ36735361-9D5E8EBA-19DC-4374-BE4A-4AC9742ABDC3Q36987086-C0658896-320F-43F7-A122-100A47236130Q36996835-5E5EAF4D-930F-4717-928C-86071F9C3204Q37026434-6FD0FB8A-54FE-42BF-9EA2-A13FC80B4671Q37038074-60507118-A462-4D94-A8D2-5CEC93782A4DQ37039426-7EC6B7D3-7AE9-4BAB-B902-7B6A4BFA234EQ37039684-FC32285E-7D41-4362-87C5-FAD0A16DA388Q37042379-D5CDFE85-52FC-4D15-8186-9C84A4BC61A3Q37298873-0C5E0E67-7478-4201-8AF4-0942F6CB31CBQ37386911-6B3316A3-BE74-49BC-B971-4C6117CED743Q37582460-3F9CA938-F089-4A34-88CB-650DC5EC8A02Q37601028-2F3E5295-05A7-4FE9-85C9-F5A36C98933FQ37842462-5822E536-039F-4C2C-9184-56EEEC52A3C3Q40250660-024AFA30-5D4F-43D3-8394-B5632A02AE7BQ41128681-85B6C72F-C03A-408B-B4E7-B2968B982E2AQ44491250-EE0C5799-9B5D-4A15-AFF1-BC359DF19044Q44897930-2E60B06C-2857-46AD-B5BD-702946CA7E98Q45041063-96E6CB0E-FF24-4976-838C-5AAB53A335EDQ49789890-EC7E0A6C-8189-4DE4-81B5-AD9E6109D490Q57123755-3726885D-08CE-45ED-A9C5-A32DD745ACD5Q59159093-F3D8CDAC-8E18-49B8-8B53-A691ED67E5EA
P2860
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on October 1977
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
High density lipoprotein metabolism in man.
@en
High density lipoprotein metabolism in man.
@nl
type
label
High density lipoprotein metabolism in man.
@en
High density lipoprotein metabolism in man.
@nl
prefLabel
High density lipoprotein metabolism in man.
@en
High density lipoprotein metabolism in man.
@nl
P2093
P2860
P356
P1476
High density lipoprotein metabolism in man.
@en
P2093
P2860
P304
P356
10.1172/JCI108833
P407
P577
1977-10-01T00:00:00Z